GET A QUOTE

Osteocalcin ELISA Kit

  • Created on the 1 February, 2017.

INTENDED USE

Human osteocalcin ELISA kit is a reliable quantitative procedure for measuring osteocalcin (OST) in human serum. This osteocalcin ELISA kit has a sensitivity detection limit of 0.8 ng/ml.

BACKGROUND

Osteocalcin (OST) which is also called bone Gla protein (B.G.P) is a 49 amino-acids peptide which contains three residues of gamma carboxyl glutamic acids and is 5800 Da in molecular weight. It is synthesised in the bone by the osteoblasts where after its production it is partly incorporated in the bone matrix, the rest of it is found to be circulating in blood. There are a large number of publications which show a direct correlation between the rate of bone formation and the levels of circulating osteocalcin but the exact physiological function is yet still unclear.

In clinical application determining the levels of osteocalcin by the procedure of osteocalcin ELISA kit is helpful in many cases for example when:
(a). monitoring bone metabolism during the perimenopause and post-menopause.
(b). monitoring bone metabolism in patients that have growth hormone deficiency, chronic renal failure, hypothyroidism and hyperthyroidism.
(c). identifying women that are at potential risk of developing osteoporosis.
(d). monitoring bone metabolism during treatment of premenopausal women with LH-RH agonists and hormone replacement therapy.

REAGENTS SUPPLIED

Reagents which are supplied with the osteocalcin ELISA kit, please following instructions for storage conditions.

1. Microtiter Plate: anti-OST monoclonal antibodies coated.
2. Conjugate: HRP labelled anti-OST (monoclonal antibodies)
3. Calibrator (1-5)
4. Zero Calibrator.
5. Controls 1+2.
6. Washing Solution.
7. Chromogen: TMB.
8. Stop Solution.

SENSITIVITY

The minimum sensitivity detection limit of osteocalcin (OST) using this human osteocalcin ELISA kit was approximately 0.8 ng/ml. The dynamic range for this ELISA assay is 1.9 – 90.0 ng/ml.

REFERENCES

  1. Osteocalcin: a potential marker of metastatic bone disease and response to treatment. Eur. J. Cancer Clin. Oncol.(1988) 24,1211-1217. R.E. Coleman, et al.
  2. Osteocalcin: Diagnostic Methods and Clinical Applications. Crit. Rev. Clin. Lab. Sci. (1991) 28, 4, 287-335. M.J. Power and P.F. Fottrell.
  3. An evaluation of serum osteocalcin in Paget’s disease of bone and its response to diphosphonate treatment. Arthritis and Rheumatism (1988) 31, 9, 1142-1147. L.A. Coulton, et al.
  4. Serum BGP: a specific marker for bone formation in postmenopausal osteoporosis. The Lancet (1984) 1091-1093. J.P. Brown et al.

ADDITIONAL INFORMATION

  • Full Name: Osteocalcin ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum
  • Sensitivity: 0.8 ng/ml

OTHER RELATED ELISA KITS

 

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford